| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 08/25/2005 | WO2004048559A8 Metabolically engineered micro-organisms having reduced production of undesired metabolic products |
| 08/25/2005 | US20050188440 Nucleotide sequences coding insect hemolymph polypeptide for use in generating disease resistant plants; microbiocides; biological pest control |
| 08/25/2005 | US20050188433 Expression vector comprising nucleotide sequences coding succinate/fumarate-transport protein for use generating and propagating plants with enhanced germination behavior |
| 08/25/2005 | US20050187378 nucleotide sequences encoding oligopeptide sequences which can render fusion partner proteins environmental stress resistant by binding thereto while conserving their intrinsic properties; recombinant vectors, and cells transformed by them |
| 08/25/2005 | US20050186676 A strain of host cells that contains a temperature sensitive variant of the gene encoding the endonuclease VII from phage T4; a cloning method that selects for PCR products that are devoid of PCR-generated mutations |
| 08/25/2005 | US20050186666 Protein expression systems |
| 08/25/2005 | US20050186665 Expressed ligand - vascular intercellular signaling molecule |
| 08/25/2005 | US20050186664 Albumin fusion proteins |
| 08/25/2005 | US20050186663 Cystine-knot fold protein |
| 08/25/2005 | US20050186661 Via peptone iv derived from soybean, supplemented with corn steep liquor, beef extract, tryptone, casein, and gelatin; bacteriocin-release-proteins; tolerant to leucine, cysteine, arginine, glycine, asparagine (BDH) and aspartic acid; heat treatment; freeze drying; for use in detergents |
| 08/25/2005 | US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 08/25/2005 | US20050186659 Methods for protein purification |
| 08/25/2005 | US20050186634 Peptides for use in culture media |
| 08/25/2005 | US20050186621 Using host cells to propagate preferential viral proteins for use in generating vaccines aganist microorganismal infection |
| 08/25/2005 | US20050186620 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 08/25/2005 | US20050186618 ADAM gene having a novel base sequence; an ADAM protein encoded by it has the protease activity and is involved in degradation of an extracellular matrix; recombinant vector comprising the DNA; recombinant host cell |
| 08/25/2005 | US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 08/25/2005 | US20050186570 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186564 Production of proteins |
| 08/25/2005 | US20050186563 Expression vector for use as transformation and gene expression tool in genetic engineering; minimum plasmid-based system for the generation of infectious RNA viruses, preferably influenza viruses, from cloned DNA |
| 08/25/2005 | US20050186560 Mammalian cell expressing viral replication protein for use as tool in identifying modulators for treatment of cell proliferative and autoimmune disorders; immunotherapy |
| 08/25/2005 | US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/25/2005 | US20050186254 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 08/25/2005 | US20050186227 For protection of fetuses from abortion; freeze drying |
| 08/25/2005 | US20050186226 treating diseases such as HIV/AIDS disease, oncological ailments, tuberculosis, rheumatics, etc. by autohaemovaccinoimmunotherapy |
| 08/25/2005 | US20050186217 Compositions produced using enteric pathogens and methods of use |
| 08/25/2005 | US20050186209 Protein between 30% but less than 100% identical to a human protein, contains a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 08/25/2005 | US20050186203 Isolated antibody bound to human insulin-like growth factor-I receptor, identification of its CDRs (complementarity-determining regions), inhibiting the tyrosine kinase activity of the IGF-IR receptor |
| 08/25/2005 | US20050186191 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis |
| 08/25/2005 | US20050186189 Treating obesity |
| 08/25/2005 | US20050186180 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 08/25/2005 | US20050186148 Prophylaxis or treatment of dental caries, dental plaque, and periodontal infection that include lactic bacteria that are not part of the resident microflora of the mouth, are low acidifying, and are capable of adhering directly to the pellicle of the teeth |
| 08/25/2005 | DE102004004901A1 Verfahren zur Herstellung von Sorbicillacton A A process for the preparation of sorbicillacton |
| 08/25/2005 | CA2556095A1 Live attenuated salmonella for use as vaccine |
| 08/25/2005 | CA2555869A1 Culture media compositions free of fetal bovine serum |
| 08/25/2005 | CA2555599A1 A culture medium for the production of filamentary fungi |
| 08/25/2005 | CA2555142A1 Cell proliferation associated with ccx ckr expression |
| 08/25/2005 | CA2550401A1 Method and compositions for detecting botulinum neurotoxin |
| 08/24/2005 | EP1566453A2 Qualitative differential splicing |
| 08/24/2005 | EP1566437A1 Adsorption of nucleic acids to a solid phase |
| 08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 08/24/2005 | EP1565554A1 Metabolically engineered micro-organisms having reduced production of undesired metabolic products |
| 08/24/2005 | EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 08/24/2005 | EP1565489A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1290150B1 Cutinase variants |
| 08/24/2005 | EP1238085B1 Bacillus thuringiensis toxin active against formicidae (ant) |
| 08/24/2005 | EP1056872B1 Dna sequences containing a transfer mechanism by conjugation |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | EP0684955B1 Nuclear matrix proteins |
| 08/24/2005 | EP0662132B1 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 08/24/2005 | CN1659438A G-protein coupled receptor ligands and methods |
| 08/24/2005 | CN1659284A Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 08/24/2005 | CN1659283A Bacillus licheniformis mutant host cell |
| 08/24/2005 | CN1659282A Bacillus licheniformis mutant host cell |
| 08/24/2005 | CN1659277A Novel phospholipases and uses thereof |
| 08/24/2005 | CN1659276A Phospholipases, nucleic acids encoding them and methods for making and using them |
| 08/24/2005 | CN1659272A Product |
| 08/24/2005 | CN1659180A Novel recombinant anticoagulant proteins |
| 08/24/2005 | CN1658940A Cell separation compositions and methods |
| 08/24/2005 | CN1657620A Characterisation of gene function using double stranded (ds) RNA inhibition |
| 08/24/2005 | CN1657613A Method for raising green trichoderma cellulase active by biological surfae active agent |
| 08/24/2005 | CN1657608A Adenosme generation bacteria and method for generating adenosine by fermentation |
| 08/24/2005 | CN1657607A Simple method for screening sulfadiazing (SD) degradating bacterial for treating SD-contxined sewage |
| 08/24/2005 | CN1657606A Method for repairing soil at high-efficient power of bacterial to emulsify petroleum |
| 08/24/2005 | CN1657605A Method of increasing hydrogen releasing efficient of chlamydomonas |
| 08/24/2005 | CN1657604A Preparation and using method of culture medium |
| 08/24/2005 | CN1657603A Mutant microorganism and method for producing peptide using the same |
| 08/24/2005 | CN1657602A Culture media for rhizoma gastrodiae honey fungus mother plant |
| 08/24/2005 | CN1657601A Hebei Amycolatopsis hebeiensis bacterial strain and preparation Norvancomycin fermented by the strain |
| 08/24/2005 | CN1657542A Marine fungi polysaccharide and its extraction method and use |
| 08/24/2005 | CN1657444A Ultra concentrated algae bacteria microecological equipment suspension type water quality modifier and its preparation method |
| 08/24/2005 | CN1657147A Organic silicon ether defoaming agent for food processing |
| 08/24/2005 | CN1216146C Strain for food preservation and its anti-bacterial product |
| 08/24/2005 | CN1216145C Bifidobacterium therm ophilum and the method for producing L-lactiv acid by utilizing it |
| 08/24/2005 | CN1216144C Metarhizium anisopliae |
| 08/24/2005 | CN1216139C Distille's yeast for brewing magma fruit liquor |
| 08/24/2005 | CN1216073C Bioactive peptide of sepuence No.4 |
| 08/24/2005 | CN1216072C Bioactive peptide of sequence No.5 |
| 08/24/2005 | CN1216071C Bioactive peptide of sequcene No.27 |
| 08/24/2005 | CN1216070C Bioactive peptide sequence No.20 |
| 08/24/2005 | CN1216069C Bioctive peptide of sequence No.25 |
| 08/24/2005 | CN1216068C Bioactive peptide of sequence No.14 |
| 08/24/2005 | CN1216067C Bioactive peptide of sequence No.15 |
| 08/24/2005 | CN1215991C Low temperature nitrobacter agent and use thereof |
| 08/23/2005 | US6933422 Nav2 channel gene-deficient mice |
| 08/23/2005 | US6933365 Mutant tyrosine repressor proteins |
| 08/23/2005 | US6933147 Human cyclic nucleotide-gated channel polypeptide |
| 08/23/2005 | US6933146 Methods and means for producing efficient silencing construct using recombinational cloning |
| 08/23/2005 | US6933142 Mammalian glycosylsulfotransferases expressed in high endothelial cells (HEC-GLCNAC6ST) and polypeptides coded by nucleic acids, used for medical diagnosis, drug screening and therapy |
| 08/23/2005 | US6933138 Comprises nucleotide sequences coding heat resistant isomerase for preparation of sugar substitute; diabetes preventive agent; detergents and cosmetics additive |
| 08/23/2005 | US6933137 Animal component free meningococcal polysaccharide fermentation and seedbank development |
| 08/23/2005 | US6933132 Regulation of immune responses by attractin |
| 08/23/2005 | US6933131 Nucleotide sequences for use in biological pest control; insecticides |
| 08/23/2005 | US6933130 Recombinants process for preparing a complete malaria antigen, gp190/MSP1 |
| 08/23/2005 | US6933125 Human c-Maf compositions and methods of use thereof |
| 08/23/2005 | US6933124 Human GABAB receptor 1 promoters |
| 08/23/2005 | US6933117 Composition for use in the automated medical and genetic analysis |
| 08/23/2005 | US6932991 Isolated and purified strain of the species Lactobacillus sanfranciscensis which produces levan. The present invention further relates to a method of producing the levan, and to a method of preparing various human or pet food products or |